Tomas Kiselak

Tomas Kiselak is a Managing Member at Fairmount Funds Management LLC, a healthcare investment firm he co-founded in April 2016. Prior to Fairmount, Mr. Kiselak was a managing director at RA Capital Management, LLC. Mr. Kiselak currently serves on the board of Viridian Therapeutics, Inc. as its chairman. He also serves as a director of Apogee Therapeutics, Inc., Dianthus Therapeutics, Inc., Spyre Therapeutics, Inc., and Zenas BioPharma, Inc., as well as several private companies. He received a bachelor’s degree in Neuroscience and Economics from Amherst College.